Phase II Proof-of-concept, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post-COVID-19 Condition (PCC)
Latest Information Update: 16 Jan 2025
Price :
$35 *
At a glance
- Drugs Plitidepsin (Primary)
- Indications Post acute COVID 19 syndrome
- Focus Proof of concept; Therapeutic Use
- Acronyms THALASSA
- 16 Jan 2025 New trial record